Commercial Space Company Risk / Opportunity Ranking

Thesis: The reviewed sources indicates Kratos has space-defense relevance, including a stated U.S. Space Force/Space Systems Command contract in membership rationale, but there are no retained direct evidence or article summaries within the 90-day recent evidence window to support a current 1 year+ opportunity thesis.

Why now: Why now is weak because no article summaries or direct evidence were retained after the March 29, 2026 cutoff; recency is therefore insufficiently supported in these reviewed sources.

Caveats: Membership rationale references support references and, but no article or retained evidence are provided, so they cannot be cited as factual support under the output rules. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0.

Thesis: No direct positive evidence is retained in the reviewed sources for KVH Industries within the selected recent evidence window.

Why now: The membership rationale says KVH appeared as a listed player in a generic defense satellite communication market report tied to article: but the reviewed sources retains zero evidence after recent evidence window and provides no, so this is too weak for a directional thesis.

Caveats: Generic market-report mention is weaker than company-specific event evidence. The support article ID is cited in the reviewed sources rationale but no article or retained evidence row is provided.

Thesis: The membership rationale indicates LandSpace is a Chinese commercial rocket company pursuing IPO funding and reusable rocket development, but the reviewed sources includes no available within the recent evidence window evidence or article summaries that can support a directional opportunity thesis in this screen.

Why now: Why-now is weak because no within the recent evidence window evidence are available, so timing, financing status, and launch progress cannot be judged from the current reviewed sources.

Caveats: Membership rationale references, and, but no article details are available here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Potential IPO/funding relevance is mentioned only in membership rationale and cannot be elevated without direct evidence.

Thesis: No direct positive evidence is available in the reviewed sources, so no opportunity thesis is supportable.

Why now: The reviewed sources only describes that Intuitive Machines acquired Lanteris for about $800M via article, but provides no available evidence, no business description, and no.

Caveats: Acquisition mention without business detail is insufficient for ranking direction. No post-recent evidence window evidence are available. Referenced has no in the reviewed sources.

Thesis: Reviewed evidence rationale suggests Lonestar is a space data storage startup with a NASA Space Act Agreement and orbital/lunar storage infrastructure, but there is no retained direct positive evidence with article inside the 90-day recent evidence window, so a positive thesis is not currently supportable.

Why now: Why now is weak because 8 articles were considered but zero remained after the March 29, 2026 cutoff, leaving no current catalyst or status confirmation.

Caveats: No recent evidence window-qualified evidence. Phase-2 rationale is not enough for directional conviction.

Thesis: Insufficient retained evidence within the reviewed sources to support a positive 1 year+ opportunity thesis.

Why now: There is no available post-recent evidence window evidence for this company. The reviewed sources notes two considered articles, but zero article IDs after recent evidence window and zero evidence retained, so recency-sensitive judgment is not possible.

Caveats: The reviewed sources say support used article IDs existed earlier, but no retained evidence are available after the 90-day recent evidence window cutoff of March 29, 2026. Absence of evidence is not positive or negative proof.

Thesis: There is a possible long-horizon opportunity if LSS is indeed participating as part of an HPS/LSS consortium building a deployable antenna reflector for a GEO telecommunications satellite, but the reviewed sources provide no available direct evidence inside the 90-day recent evidence window to validate scale, timing, or economics.

Why now: There is no clear 'now' catalyst in the available evidence. The reviewed sources states zero article IDs after recent evidence window and zero evidence available after recent evidence window, so recency is unverified for a 1 year+ ranking.

Caveats: Phase-2 rationale references consortium work tied to: and: but the reviewed sources does not include article summaries or for those items. Coverage debug shows zero evidence after recent evidence window, so no direct claim can be validated as current. Cohort review status is not a directional signal.

Thesis: Lumen Orbit is only described as being mentioned among initiatives related to orbital data centers in an article centered on other companies, which is too weak and indirect to support a positive thesis.

Why now: No dated or citable event evidence is available. The reviewed sources indicates provisional single-article context tied to article id: but no or summary is provided and no evidence survived recent evidence window.

Caveats: Support level is explicitly provisional_single_article_context, which is weaker than company-specific event or fact evidence. No current evidence is provided for article: preventing direct citation. Scores remain minimal due to lack of evidence, not a strong negative view.

Thesis: Reviewed evidence rationale says Lunar Outpost won NASA moon-base or lunar terrain vehicle related work, but no retained article/evidence are available here to substantiate an investable opportunity view.

Why now: There is no retained post-recent evidence window evidence row in these reviewed sources despite membership rationale referencing NASA-related wins, so timing support is insufficient.

Caveats: Membership rationale is not enough for a strong thesis without cited retained evidence. Coverage after recent evidence window is effectively zero in these reviewed sources.

Thesis: Only minimal historical profile-style support is noted for Lunar Outpost as a private company focused on space robotics and lunar surface mobility, but no direct positive evidence survived the 90-day recent evidence window, so there is not enough local evidence to support a substantive 1 year+ opportunity thesis.

Why now: No within the recent evidence window company-specific catalyst or business-state change is available. Coverage debug shows 0 article IDs after recent evidence window and 0 evidence after recent evidence window, with cutoff date March 29, 2026.

Caveats: Reviewed evidence references only a profile-like article via membership rationale, not available direct evidence: but no is provided in these reviewed sources. No current source-cited evidence was found in the reviewed sources.

Thesis: The reviewed sources places M-tron in a 'public space names' market article, but that is thematic basket context rather than direct proof of company-specific opportunity.

Why now: No direct catalyst or citable business-state evidence is available. The reviewed sources references article ids: and: but provides no and no retained evidence.

Caveats: The reviewed sources explicitly says the evidence is mostly thematic/stock-basket context rather than direct business description. No or quotes are provided for direct citation.

Thesis: No positive thesis is supportable from the retained evidence in these reviewed sources. Phase-2 rationale references a partnership with D-Orbit for an electric propulsion demo tied to article, but no representative article, quote, or retained within the recent evidence window evidence row is available here, so the opportunity case cannot be grounded to reviewed sources-standard evidence.

Why now: Why now is weak because the reviewed sources' evidence recent evidence review shows zero kept rows after the 90-day cutoff ending March 29, 2026 and coverage data shows articles after recent evidence window of 0, so recency is not established from retained evidence.

Caveats: Phase-2 membership rationale cites but no or retained evidence row is provided in these reviewed sources, so it cannot be used for factual claims. Coverage after recent evidence window is effectively empty: evidence recent evidence review cutoff_date March 29, 2026 with kept_rows 0. Scores reflect insufficient evidence, not a fundamental bearish or bullish view.

Thesis: No positive thesis is supportable from retained evidence. Phase-2 rationale notes Manastu Space is listed among Indian new-space startups and mentions 'Manastu Space thrusters' tied to article, but the reviewed sources have no representative article or retained evidence row after recent evidence window.

Why now: Why now is weak because no evidence survived the 90-day recent evidence window in the available reviewed sources; evidence recent evidence review kept_rows is 0 and coverage data articles after recent evidence window is 0.

Caveats: Phase-2 rationale is not enough for a factual claim without and retained evidence detail. No within the recent evidence window direct evidence is available. Low scores reflect absence of usable evidence.

Thesis: The membership rationale suggests launch-readiness relevance, but no retained 90-day direct positive evidence is available to support an opportunity thesis.

Why now: The reviewed sources show zero retained article IDs and zero evidence after recent evidence filtering, so there is no recent company-specific evidence base for a 1 year+ directional call.

Caveats: Historical membership support references article IDs, but no post-recent evidence window evidence are served here. Low scores reflect insufficient evidence, not an evaluated business conclusion.

Thesis: The reviewed sources only mentions Marlan Space as an IHC affiliate and partner in the Orbitworks constellation effort, which is context-only and insufficient for a positive thesis without direct company-specific progress evidence.

Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Marlan Space.

Caveats: Phase-2 membership rationale references article: but the reviewed sources provide no for citation. Partnership context alone should not be treated as propagated operating evidence under the evidence standard.

Thesis: There is insufficient direct evidence in the reviewed sources to support an opportunity thesis beyond generic market-report inclusion as a key player in optical satellite markets.

Why now: No 'why now' is evidenced. The reviewed sources show zero post-recent evidence window available evidence despite a large article universe.

Caveats: Phase-2 rationale references: but no or summary is provided. Generic market-report mention is weaker than direct company event/fact evidence. Coverage debug shows zero evidence after recent evidence window.

Thesis: A weak opportunity case exists only because the phase2 rationale says MizarVision images were referenced in a geopolitical article, implying some satellite-imagery relevance. However, the reviewed sources does not provide direct company-specific operating evidence or a citable article summary/.

Why now: No in-recent evidence window article summary or evidence row is available for MizarVision. The only timing cue is an uncited phase2 rationale referencing article id without.

Caveats: Evidence is indirect and not strongly company-specific according to the reviewed sources rationale. No citable article or summary is provided for the referenced article id. No evidence were available after recent evidence window.

Thesis: No affirmative opportunity thesis is supportable from retained evidence. Phase-2 rationale says Moog is cited in a satellite propulsion market report, but no representative article details or retained evidence row is present in the reviewed sources.

Why now: Why now is weak because the reviewed sources have no within the recent evidence window evidence; evidence recent evidence review kept_rows is 0 and coverage data articles after recent evidence window is 0.

Caveats: The lawsuit reference exists only in phase-2 rationale without or retained evidence detail, so it is too weak for a material risk call. No direct evidence arrays are populated. Score reflects limited unresolved risk context plus very sparse evidence.

Thesis: The reviewed sources rationale says Moog supplies components for NASA SLS and is involved in satellite propulsion and components, but no direct positive evidence with article survives the 90-day recent evidence window, so opportunity support is insufficient.

Why now: Why now is weak because despite 72 articles considered, zero article IDs and zero evidence were retained after the March 29, 2026 cutoff, preventing any current sequencing or catalyst assessment.

Caveats: No admissible post-recent evidence window evidence. Membership review rationale is contextual only and not a directional scoring basis by itself.

Thesis: Membership rationale indicates Moonshot Space is developing an electromagnetic accelerator for lunar supplies and that a co-founder invested $6 million, which could support a long-duration moon logistics thesis, but the reviewed sources includes no retained direct evidence or article summaries inside the recent evidence window.

Why now: There is no strong why-now signal because coverage data shows zero articles after recent evidence window and zero evidence after recent evidence window; the cited support article is referenced only in membership rationale without a in the reviewed sources.

Caveats: No article is provided for membership support article, so the underlying factual statements cannot be elevated beyond low-confidence context. No direct positive or direct negative evidence are available after recent evidence window. Long-horizon potential exists, but current reviewed sources support is too thin for a stronger score.

Thesis: Main risk is execution and evidence uncertainty rather than a documented adverse event. The reviewed sources only provides undated supporting article context about a seed round and intended use of proceeds, which leaves recency, funding durability, and commercialization progress uncertain.

Why now: Why now is weak because the only support is undated context articles; the reviewed sources explicitly says no is available, so recency-sensitive claims should be treated cautiously for these funding and expansion statements

Caveats: Evidence is undated; recency is uncertain. Support is supporting article context only, not direct structured positive event evidence. Same funding story appears in two articles and should not be treated as independent confirmation.

Thesis: The reviewed sources provide no retained article or evidence after recent evidence window to quantify contract size, award stage, revenue timing, or execution burden, so the opportunity is plausible but not well-validated and downside cannot be measured.

Why now: The reviewed sources provide no post-recent evidence window detailed evidence, but the membership rationale specifically references selection for the Andromeda program via article. Because the underlying article summary/ is not included here, timing and magnitude are uncertain.

Caveats: No representative article or is included for the cited Andromeda selection evidence. Selection for a program is positive, but without award size or timing the business impact is unclear. Scores are capped by missing direct article-level support.

Thesis: Risk is slightly higher than base because the company is described only through older membership rationale involving development of the Terran R reusable rocket and financing participation, without current evidence confirming execution progress, but this remains low-conviction because no direct negative evidence is retained.

Why now: Why now is weak because there are no retained post-cutoff article summaries or evidence in the reviewed sources.

Caveats: No retained evidence after recent evidence window. The modest risk uplift reflects uncertainty from lack of current confirmation, not a direct adverse event.

Thesis: There is also strategy-execution risk because the phase-2 rationale says the project is early stage with no final timeline or finalized investment, but again the reviewed sources does not provide retained article-level citations for those statements here, so risk remains low-scored due to weak grounding.

Why now: Why now is weak because although the phase-2 rationale references articles, and: regarding LEO satellite communication plans, no or retained evidence are available and coverage data shows articles after recent evidence window of 0.

Caveats: Phase-2 rationale suggests planning activity, not confirmed operating status, and cannot be cited as fact without /evidence. No representative articles or evidence are available after recent evidence window. Scores are constrained by insufficient retained evidence, not by a definitive neutral business view.

Thesis: The reviewed sources supports some development-stage and timing risk because the cited milestone is still a planned future demonstration mission in 2027, but the evidence is old and sparse.

Why now: The only concrete article summary is dated February 23, 2026 and therefore outside the 90-day recent evidence window cutoff of March 29, 2026; it says Remondo plans to launch its first mission in 2027 to demonstrate PAIS, which is interesting for long-horizon monitoring but not strong enough for a current thesis.

Caveats: All dated evidence was dropped by the 90-day recent evidence filter. Only one older article is available, so corroboration is limited.

Thesis: Risk is mostly uncertainty from missing current evidence rather than explicit adverse developments. Without available direct evidence, it is hard to assess whether financing, product progress, or customer conversion remains on track.

Why now: Why now is limited because no within the recent evidence window evidence were retained for ranking, so recency and durability cannot be tested.

Caveats: Phase-2 membership rationale references, but no or available evidence row is provided in these reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. The financing claim cannot be elevated beyond low conviction without direct available evidence.

Thesis: As an apparent pre-launch rocket company, execution risk may be elevated, but the reviewed sources does not provide retained adverse evidence, so only a modest evidence-light risk score is justified.

Why now: No retained article or event evidence remains after recent evidence filtering; the only hint is a membership rationale referencing first test-launch focus via article: without an included summary.

Caveats: Cannot treat membership rationale alone as strong directional proof. No article summary or retained evidence row is included for article

Thesis: The same contextual pivot language also creates execution and qualification risk because the reviewed sources does not firmly establish Rocket One as a current operating space company in the target categories, and there is no direct post-recent evidence window evidence of contracts, product milestones, financing, or customer traction.

Why now: Membership rationale cites articles, and: describing a renamed former biotech company pivoting toward space/defense AI chips and nano-launch or nanosatellite enablement, but coverage data still shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. unavailable in reviewed sources.

Caveats: Context suggests strategic intent, not proven execution. No article are provided for cited membership-rationale articles. No direct evidence survive recent evidence filtering.

Thesis: No material adverse evidence is available in the reviewed sources for RTX, so there is no supported risk thesis from the provided evidence.

Why now: Although the membership rationale references articles, and: the reviewed sources loads zero reviewed evidence after recent evidence filtering, so there is no directly scorable current catalyst from local evidence.

Caveats: Very large article universe exists, but article count is not conviction. Membership support references potentially meaningful articles, but those summaries/evidence are not available here and therefore cannot be elevated into direct scoring evidence.

Thesis: No material adverse evidence is available, but there is also no current direct evidence to establish momentum or deterioration.

Why now: Why-now support is absent because coverage data shows zero evidence after recent evidence window.

Caveats: Phase2 rationale cites 2026-04, and: but no representative articles or evidence are available for direct citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low score reflects missing current reviewed sources evidence rather than negative evidence.

Thesis: No direct adverse evidence is available, but lack of current evidence means the reviewed sources cannot support a strong opportunity or risk thesis.

Why now: The reviewed sources includes no representative article or evidence row inside the 90-day recent evidence window, so there is no dated near-current catalyst to anchor a 1 year+ view from this screen alone.

Caveats: No retained evidence after recent evidence window. Referenced acquisition/shipment facts are only in the phase-2 rationale here, not in cited retained evidence.

Thesis: The main risk is evidentiary: no direct adverse evidence is available, but there is also no in-window evidence confirming current execution, funding status, customer traction, or program progress, limiting confidence in any opportunity case.

Why now: There is no reliable 'why now' catalyst in the available evidence. The reviewed sources notes support/article IDs were used for membership, but after the 90-day recent evidence filter there were 0 article IDs after recent evidence window and 0 evidence available, so recency is uncertain for any thesis.

Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article IDs, and: but the reviewed sources does not provide or article summaries for citation. Without -bearing evidence, factual support is limited to reviewed sources-level membership rationale only.

Thesis: Main risk is evidence opacity rather than explicit adverse business events: the reviewed sources show 47 articles considered but zero article IDs after recent evidence window and zero evidence available after dedupe, leaving business-state recency uncertain.

Why now: Why now is weak because the 90-day reviewed sources contain no available evidence after recent evidence window for SEALSQ, despite article history existing in the broader corpus.

Caveats: No direct positive or negative evidence available after recent evidence window. Membership rationale references article IDs and, but the reviewed sources provide no for them, so they cannot be cited as factual support under the the evidence standard.

Thesis: The reviewed sources show no direct adverse evidence. Main risk is that the available evidence is supporting article context rather than a fuller company-specific contract filing, and one related transportation agreement is older than the recent evidence window.

Why now: The key evidence is recent and within the recent evidence window: a June 11, 2026 SpaceNews article says SES was selected last month as a prime contractor under the PTS-G program, with K2 Space providing SES's satellite platform

Caveats: Reviewed evidence is still supporting article context rather than a direct company filing. The Impulse transportation agreement is older and outside the 90-day recent evidence window.

Thesis: The main risk is evidentiary rather than operational: the reviewed sources itself says mapping between Sierra Nevada Corporation and Sierra Space is not fully explicit, and the surviving support is supporting article context rather than direct company events.

Why now: The key surviving context is dated April 8, 2026, within the 90-day recent evidence window, and references recent contract awards under Andromeda that could matter over a 1 year+ horizon if they convert into meaningful program work. Article timestamp: April 8, 2026, basis: source date. Evidence is from at

Caveats: Evidence is supporting article context, not a direct structured positive event row for Sierra Nevada Corporation. Reviewed evidence explicitly notes entity-resolution ambiguity between Sierra Nevada Corporation and Sierra Space. The second representative article is older than the 90-day recent evidence window and should not drive recency, published September 2, 2025.

Thesis: Risk is mainly thesis slippage risk: the company may be an enabling software layer rather than a direct space operator, and the reviewed sources contain no direct business traction or adverse evidence for ranking.

Why now: Why now is weak because only article is referenced in the membership rationale, with no and no reviewed evidence to validate timing or materiality for the ranking horizon.

Caveats: No article is available for article. Space exposure may be indirect rather than core. Coverage debug shows zero post-recent evidence window evidence.

Thesis: Risk is mainly execution and information opacity risk because the reviewed sources lack direct dated rows on revenue, contracts, milestones, or setbacks.

Why now: Why now is weak because the only support referenced is article: in the membership rationale, and the reviewed sources provide neither a nor a reviewed evidence row to substantiate timing beyond that summary.

Caveats: No article is available for article Coverage debug shows zero post-recent evidence window evidence for ranking. Funding support alone, even if true, would not establish durable attractiveness without additional execution evidence.

Thesis: The same evidence is weak for timing because it is undated supporting article context rather than direct event/fact evidence, so current economic significance and sequencing are uncertain

Why now: This is one of the only companies in the screen with any current evidence surviving the recent evidence window, but it is undated supporting context, so why-now confidence is still limited

Caveats: Evidence is undated and supporting article context only. Same article appears in multiple weak-context rows and is not independent confirmation. No direct positive event/fact beyond supporting context.

Thesis: Risk is primarily uncertainty and execution risk because no direct positive or negative rows are preserved in the ranking reviewed sources despite the membership rationale referencing funding and technology progress.

Why now: Why now is weak because the reviewed sources cites articles: and: in the membership rationale, but no or reviewed evidence are provided for ranking-grade citation.

Caveats: No article are provided for the referenced support articles. Cannot convert broad space-tech relevance into a strong opportunity thesis without direct evidence. Coverage after recent evidence window is empty.

Thesis: Primary risk in this ranking is stale evidence: there is no retained within the recent evidence window evidence to confirm current contracts, fleet expansion, or demand. That makes the near-current business state uncertain in these reviewed sources.

Why now: Why now is weak because the only cited article, March 4, 2025), falls outside the 90-day recent evidence window and was dropped; recency therefore does not support an active thesis here.

Caveats: No evidence were kept after recent evidence filtering. Cannot rely on dropped 2025 evidence for a current ranking. Company-category relevance is not sufficient for a directional opportunity thesis.